Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 239 M
EBIT 2016 -153 M
Net income 2016 -186 M
Finance 2016 134 M
Yield 2016 -
Sales 2017 287 M
EBIT 2017 -154 M
Net income 2017 -179 M
Finance 2017 155 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 10,6x
EV / Sales2017 8,71x
Capitalization 2 654 M
More Financials
Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery.It operates through two segments: Drug Discovery & Development Operations and Akcea.The Drug Discovery & Development Operations segment provides drugs to treat a variety of health conditions,... 
Sector
Biotechnology & Medical Research
Calendar
07/13 | 02:30pmShareholder meeting
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
06/22 IONIS PHARMACEUTICALS : to Host R&D Day
06/16 IONIS PHARMACEUTICALS : Novel imaging model helps reveal new therapeutic target ..
06/08DJJudge Sides With Gilead in Drug-Patent Dispute -- WSJ
06/07DJJudge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents
06/07DJJudge Sides With Gilead Against Merck in Hepatitis C Case
06/07 IONIS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders ..
06/03 Biotechnology Stocks Giving Back Ground After Recent Gains
06/02 IONIS PHARMACEUTICALS : Biotechnology Stocks Show Significant Move To The Upside
06/02 IONIS PHARMACEUTICALS : and MD Anderson Form Strategic Alliance to Advance Novel..
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against a Late-Stage..
More news
Sector news : Biotechnology & Medical Research - NEC
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
2015 Game Plan For The Week - Cramer's Mad Money (12/18/15)
2015 PREMARKET BIOTECH DIGEST : Portola's Milestone, Shkreli Resigns, BioMarin DMD Dr..
2015 Isis Pharma has had enough, name changed to Ionis Pharmaceuticals
2015 Bear Afoot? No Recession Needed For A Possible Sighting
2015 PREMARKET BIOTECH DIGEST : Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Gui..
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions